Acquired melanin pigmentation/Benign tumors
Conditions
Interventions
None listed
Sponsors
Kao Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Men and women aged between 20 and 59 years old. (2) Those who wish to undergo or are planning to undergo aesthetic treatment. (3) Patients with benign small tumors (seborrheic keratosis, soft fibroma, etc.) or acquired hyperpigmentation (senile hyperpigmentation, spermatorrhea, etc.) as determined by the principal investigator.
Exclusion criteria
Exclusion criteria: (1) Those who suffer from chronic inflammatory skin diseases (atopic dermatitis, psoriasis, etc.). (2) Those who have extreme sunburn on the face. (3) Those who have a tendency to develop keloids. (4) Those who are determined by the principal investigator to require treatment for a disease. (5) Women who are breastfeeding, pregnant, or potentially pregnant. (6) Those who are otherwise determined to be unsuitable by the Principal Investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of a Photographic Scale for Assessing the Healing Process: Longitudinal Observation of Treatment Sites | — |
Secondary
| Measure | Time frame |
|---|---|
| ANTERA measurement (melanin, hemoglobin, L* value, a* value, b* value, concavity, scar area) | — |
Countries
Japan
Contacts
Public ContactYoshie Shimotoyodome
Kao Corporation Human Healthcare Product Research
Outcome results
None listed